OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment
Dongdong Luo, Xingyang Qiu, Qingquan Zheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10655-10686
Closed Access | Times Cited: 8
Dongdong Luo, Xingyang Qiu, Qingquan Zheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 10655-10686
Closed Access | Times Cited: 8
Showing 8 citing articles:
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions
Angela Rina, Debora Maffeo, Francesca Minnai, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2882-2882
Open Access | Times Cited: 5
Angela Rina, Debora Maffeo, Francesca Minnai, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2882-2882
Open Access | Times Cited: 5
Discovery of the First Potent ROR1 Degrader for the Treatment of Non-Small Cell Lung Cancer
Jinlin Li, Lin Li, Hou Cai-yun, et al.
European Journal of Medicinal Chemistry (2025), pp. 117325-117325
Closed Access
Jinlin Li, Lin Li, Hou Cai-yun, et al.
European Journal of Medicinal Chemistry (2025), pp. 117325-117325
Closed Access
Development of indole hybrids for potential lung cancer treatment-part I: nitrogen-containing six-membered aromatic heterocycles
Shijia Zhao, Zhi Xu
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
Shijia Zhao, Zhi Xu
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
Lin Li, Weixue Huang, Xiaomei Ren, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 3
Lin Li, Weixue Huang, Xiaomei Ren, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 3
Novel humanized monoclonal antibodies against ROR1 for cancer therapy
Rong Wei, Xun Liao, Jiao Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Rong Wei, Xun Liao, Jiao Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Discovery of the First Potent Ror1 Degrader for the Treatment of Non-Small Cell Lung Cancer
Fengtao Zhou, Jinlin Li, Lin Li, et al.
(2024)
Closed Access
Fengtao Zhou, Jinlin Li, Lin Li, et al.
(2024)
Closed Access
Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibition
Fang Luo, Jie Liu, Rongtao Wang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118011-118011
Closed Access
Fang Luo, Jie Liu, Rongtao Wang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 117, pp. 118011-118011
Closed Access
Relevance of Small Molecule Inhibitors in Advancing Cancer Therapeutics
Meltem Kaya, Gamze Tuna, Selda Yılmaz
(2024), pp. 103-117
Closed Access
Meltem Kaya, Gamze Tuna, Selda Yılmaz
(2024), pp. 103-117
Closed Access
